Abstract
This study uses Medicare claims data to compare spending for hip and joint replacements among hospitals with voluntary vs mandatory participation vs nonparticipation in the Medicare Bundled Payments for Care Improvement program between 2011 and 2017.
Medicare has used both voluntary and mandatory participation to engage health care organizations in value-based payment models. Compared with mandatory participants, voluntary participants are assumed to achieve greater savings because they self-select into programs due to greater opportunity to reduce spending. However, no empirical data exist comparing savings under mandatory vs voluntary programs.
In 2013, Medicare started the voluntary Bundled Payments for Care Improvement (BPCI) program, which included hip and knee joint replacements. In 2016, under the Comprehensive Care for Joint Replacement (CJR) program, Medicare randomized hospitals in 75 metropolitan statistical areas to receive mandatory hip and knee joint replacement bundled payments, whereas hospitals in 121 metropolitan statistical areas continued receiving fee-for-service payments. This created an opportunity to examine the association between voluntary vs mandatory hospital participation in a bundled payment program for joint replacements and episodic spending changes.1,2,3
Methods
The University of Pennsylvania institutional review board approved the study with a waiver of consent. Following prior work,3,4 we used 2011-2017 Medicare claims to evaluate spending among hospitals in metropolitan statistical areas randomized via the CJR program and weighted by strata used in the Medicare randomization protocol. The hospitals randomized to mandatory bundled payments in the 75 metropolitan statistical areas in the CJR program were divided into hospitals (1) that self-selected into bundled payments for joint replacement via the BPCI program before being subject to the CJR program (voluntary hospitals) or (2) that were not participating in the BPCI program for joint replacement prior to CJR program participation (mandatory hospitals). Hospitals were assigned to these groups regardless of subsequent dropout.
Hospitals in the 121 metropolitan statistical areas randomized to continue receiving fee-for-service payments were defined as the comparison group if they did not participate in the BPCI program for joint replacements prior to CJR program participation (hospitals not participating in the bundled payment program) or were excluded if they did. Consistent with prior evidence that joint replacement bundle programs target institutional postacute care,2,3 the outcome measure selected was episodic spending on institutional care (the sum of index hospitalizations and 90-day postdischarge readmissions, skilled nursing, inpatient rehabilitation, and long-term acute care facility spending). All spending estimates were adjusted for inflation into 2017 dollars.
To account for time-varying entry into the BPCI program and the influence of BPCI program participation on a hospital’s episodic spending during the period preceding CJR program participation, we used event study methods to examine changes in spending before and after starting the bundled payment program (ie, the exposures were time-varying indicators of BPCI or CJR program participation). Risk-adjusted values were estimated for each hospital group during their common periods before and after starting the bundled payment program using generalized linear difference-in-differences models that included quarter-year fixed effects, hospital fixed effects that adjusted for time-invariant hospital characteristics, patient and time-varying market characteristics, and standard errors clustered at the metropolitan statistical area level. There were nondivergent trends in episodic spending across hospital groups during the period before starting the bundled payment program.
Statistical tests were 2-sided and considered significant at α = .05. Analyses were conducted using Stata version 16.0 (StataCorp).
Results
The sample consisted of 1 346 756 Medicare fee-for-service beneficiaries undergoing joint replacement surgery at 92 voluntary hospitals, 752 mandatory hospitals, and 894 hospitals not participating in the bundled payment program (Table 1). Voluntary hospitals were larger than mandatory and nonparticipant hospitals and were more likely to be nonprofit, teaching institutions. Compared with patients at other hospitals, patients at voluntary hospitals were more likely to be non-White individuals in markets with a higher penetration of accountable care organizations.
Table 1. Hospital, Patient, and Market Characteristics by Hospital Participation in Bundled Payment Program, 2011-2017.
Hospitals participating in bundled payment program | Hospitals not participating in bundled payment program | P value | ||
---|---|---|---|---|
Voluntary | Mandatory | |||
Hospital characteristics | ||||
No. of hospitals | 92 | 752 | 894 | |
Total No. of hospital beds, mean (SD) | 367 (321) | 279 (250) | 255 (228) | <.001 |
Profit status, No. (%) | ||||
Nonprofit | 71 (78.0) | 458 (62.1) | 551 (63.3) | .002 |
For profit | 19 (20.9) | 186 (25.2) | 238 (27.4) | |
Government | 1 (1.1) | 93 (12.6) | 81 (9.3) | |
Hospital status, No. (%) | ||||
Major teaching | 16 (17.6) | 76 (10.3) | 92 (10.6) | .004 |
Minor teaching | 54 (59.3) | 349 (47.4) | 400 (46.0) | |
Nonteaching | 21 (23.1) | 312 (42.3) | 378 (43.5) | |
Safety net hospitals, No. (%) | 19 (20.7) | 230 (30.6) | 192 (21.5) | <.001 |
Joint replacement complication rate, mean (SD)a | 2.77 (0.58) | 2.78 (0.55) | 2.75 (0.54) | .57 |
Risk-adjusted readmission rate, mean (SD)a | 4.57 (0.60) | 4.62 (0.56) | 4.61 (0.59) | .76 |
Patient characteristics | ||||
No. of episodes | 147 052 | 576 505 | 829 838 | |
No. of patients | 128 438 | 500 253 | 718 065 | |
Age at admission, mean (SD), y | 73.5 (7.5) | 73.2 (7.8) | 73.1 (7.7) | <.001 |
Sex, No. (%) | ||||
Female | 52 322 (35.6) | 208 440 (36.2) | 303 369 (36.6) | <.001 |
Male | 94 730 (64.4) | 368 065 (63.8) | 526 469 (63.4) | |
Race and ethnicity, No. (%)b | ||||
White | 128 674 (87.5) | 513 480 (89.1) | 751 220 (90.5) | <.001 |
Black | 11 101 (7.6) | 35 194 (6.1) | 47 763 (5.8) | |
Otherc | 7277 (5.0) | 27 831 (4.8) | 30 855 (3.7) | |
Medicare and Medicaid dual eligibility, No. (%) | 12 185 (8.3) | 60 815 (10.6) | 76 641 (9.2) | <.001 |
Market characteristics | ||||
Medicare Advantage, median (IQR), %d | 0.31 (0.27-0.42) | 0.32 (0.25-0.45) | 0.30 (0.21-0.40) | <.001 |
Accountable care organizations, median (IQR), %e | 0.1 (0-0.2) | 0.02 (0-0.2) | 0.02 (0-0.2) | <.001 |
Hospital Herfindahl-Hirschman Index, median (IQR)f | 761 (394-1571) | 1060 (629-3193) | 2151 (633-3513) | <.001 |
Abbreviation: IQR, interquartile range.
Obtained directly as rates from Hospital Compare.
Obtained from Medicare claims, which contained White and Black categories that were used directly in the analysis. Information about race was assessed due to the potential relationship between patient race and both receipt of joint replacement in the bundled payment program and spending on institutional care.
This category included Asian, Hispanic, North American Native, and other.
Defined based on the proportion of all Medicare beneficiaries enrolled.
Defined as the proportion of all Medicare fee-for-service beneficiaries enrolled.
Measure of market concentration in which higher values represent more concentration (lower competition) and lower values represent less concentration (greater competition). In this study, this index represents the concentration of hospitals in a given market.
Risk-adjusted episodic spending decreased among voluntary hospitals from $21 182 before bundled payments to $18 452 after bundled payments; among mandatory hospitals, spending decreased from $18 390 to $15 652; and among hospitals not participating, spending decreased from $17 132 to $14 871 (Table 2). Compared with hospitals not participating, both voluntary hospitals (difference-in-differences estimate, −$469 [95% CI, −$795 to −$142]; P = .005) and mandatory hospitals (difference-in-differences estimate, −$477 [95% CI, −$771 to −$183]; P = .002) exhibited differentially lower risk-adjusted episodic spending. Voluntary and mandatory hospitals did not exhibit differential changes in risk-adjusted episodic spending (difference-in-differences estimate, −$8 [95% CI, −$337 to $322]; P = .96).
Table 2. Spending on Institutional Care Before and After Participation in Hip and Knee Joint Replacement Bundled Payment Program, 2011-2017.
Hospitals participating in bundled payment program | Hospitals not participating in bundled payment program | Difference-in-differences estimate (95% CI), $a | ||||||
---|---|---|---|---|---|---|---|---|
Voluntary | Mandatory | |||||||
Before bundled payment | After bundled payment | Before bundled payment | After bundled payment | Before bundled payment | After bundled payment | Voluntary hospitals vs hospitals not participating in bundled payment program | Mandatory hospitals vs hospitals not participating in bundled payment program | |
No. of hospitals | 92 | 92 | 744 | 710 | 879 | 855 | ||
No. of episodes | 73 462 | 73 590 | 414 675 | 161 830 | 593 629 | 236 209 | ||
Spending on institutional care (95% CI), $ | 21 182 (21 022 to 21 343) | 18 452 (18 144 to 18 760) | 18 390 (18 230 to 18 551) | 15 652 (15 410 to 15 894) | 17 132 (16 972 to 17 293) | 14 871 (14 692 to 15 050) | −469 (−795 to −142)b | −477 (−771 to −183)c |
Calculated using generalized linear models and a time-varying indicator of participation in the Bundled Payments for Care Improvement (BPCI) program or the Comprehensive Care for Joint Replacement program and hospital-specific bundled payment periods for voluntary hospitals based on time-varying participation in the BPCI program. Models included hospital fixed effects (thereby controlling for time-invariant hospital characteristics) and were additionally adjusted for patient and time-varying market characteristics. Estimated risk-adjusted spending values were reported for a fixed period of 2011 quarter 1 to 2013 quarter 3 (the period before bundled payment common to all groups) and a fixed period of 2016 quarter 2 to 2017 quarter 3 (the period after bundled payment common to all groups) to align with difference-in-differences reporting standards. Voluntary and mandatory hospitals did not exhibit differential changes in risk-adjusted episodic spending (difference-in-differences estimate, −$8 [95% CI, −$337 to $322]; P = .96).
P = .005.
P = .002.
Discussion
Hospitals in bundled payment programs achieved lower episodic spending for hip and knee replacements than hospitals not participating in the programs, but spending changes did not differ between the voluntary and mandatory hospitals. This result does not support the concept that organizations perform better when self-selecting into programs.5,6
Study limitations include residual confounding and limited generalizability to other payment models or non–joint replacement bundled payment programs. Nonetheless, these findings may inform policy debates about the benefits of mandatory vs voluntary payment models.
Section Editor: Jody W. Zylke, MD, Deputy Editor.
References
- 1.Navathe AS, Emanuel EJ, Venkataramani AS, et al. Spending and quality after three years of Medicare’s voluntary bundled payment for joint replacement surgery. Health Aff (Millwood). 2020;39(1):58-66. doi: 10.1377/hlthaff.2019.00466 [DOI] [PubMed] [Google Scholar]
- 2.Finkelstein A, Ji Y, Mahoney N, Skinner J. Mandatory Medicare bundled payment program for lower extremity joint replacement and discharge to institutional postacute care: interim analysis of the first year of a 5-year randomized trial. JAMA. 2018;320(9):892-900. doi: 10.1001/jama.2018.12346 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Barnett ML, Wilcock A, McWilliams JM, et al. Two-year evaluation of mandatory bundled payments for joint replacement. N Engl J Med. 2019;380(3):252-262. doi: 10.1056/NEJMsa1809010 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Liao JM, Wang R, Mishra A, et al. Spillover effects of mandatory hip and knee replacement surgery bundles in Medicare. Healthc (Amst). 2020;8(4):100447. doi: 10.1016/j.hjdsi.2020.100447 [DOI] [PubMed] [Google Scholar]
- 5.Liao JM, Pauly MV, Navathe AS. When should Medicare mandate participation in alternative payment models? Health Aff (Millwood). 2020;39(2):305-309. doi: 10.1377/hlthaff.2019.00570 [DOI] [PubMed] [Google Scholar]
- 6.Dickson V. CMS cancels two mandatory pay models and scales back a third. Accessed April 7, 2021. https://www.modernhealthcare.com/article/20170815/NEWS/170819935/cms-cancels-two-mandatory-pay-models-and-scales-back-a-third